Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer



Status:Recruiting
Conditions:Ovarian Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - 90
Updated:9/5/2018
Start Date:March 22, 2018
End Date:July 2019
Contact:Kirsten Swingle
Email:kirsten.swingle@nyumcc.org
Phone:646 501 4834

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to determine the feasibility of routine referral to genetic
counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or
fallopian tube cancer.


Inclusion Criteria:

- All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal,
fallopian tube or extra- uterine mullerian cancer.

- All subjects must have either undergone primary surgery or be planning neoadjuvant
chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube
cancer.

- All subjects must be able to comprehend and communicate in English.

- All subjects must agree to participate.

- A previous diagnosis of cancer is not an exclusion criterion.

- Previous genetic screening is not an exclusion criterion.

Exclusion Criteria:

- Patients who do not meet the above inclusion criteria.

- Patients with a diagnosis of a low malignant potential mullerian tumor.

- Patients who are not proficient in English language because the survey aspect of this
study is comprised of 4 validated surveys that are only available in English language.
We found this trial at
1
site
New York University School of Medicine
550 1st Ave
New York, New York 10016
(212) 263-7300
Principal Investigator: Douglas Levine, MD
Phone: 646-501-4834
New York University School of Medicine NYU School of Medicine has a proud history that...
?
mi
from
New York, NY
Click here to add this to my saved trials